Scilex Holding (SCLX) Notes Payables (2020 - 2025)

Scilex Holding (SCLX) posted quarterly Notes Payables of $800000.0 for Q3 2025, down 95.92% on a QoQ basis from $19.6 million in Q4 2021.

Scilex Holding (SCLX) Notes Payables (2020 - 2025) Analysis & Trends

Scilex Holding (SCLX) has reported Notes Payables for 3 consecutive years, with $800000.0 the latest figure, recorded in Q3 2025.

In Q3 2025, Notes Payables changed N/A year-over-year to $800000.0; the TTM figure through Sep 2025 stood at $800000.0 (changed N/A YoY), while the FY2021 annual figure was $19.6 million, up 15586.4% from the prior year.
Notes Payables came in at $800000.0 for Q3 2025 at Scilex Holding, down from $19.6 million in the prior quarter.
The five-year high for Notes Payables was $19.6 million in Q4 2021, with the low at $800000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Scilex Holding	54.30 Mn	-95.62 Mn	4.15 Mn

Download Data